摘要
目的:观察疏血通注射液对慢性肺源性心脏病合并心房颤动患者的临床疗效。方法:68例患者随机分为观察组和对照组,每组34例。两组患者均常规给予低流量吸氧、化痰平喘、维持水电解质平衡、纠正酸碱平衡紊乱等对症支持处理,合并感染者根据病原学选择敏感的抗生素治疗,必要时采用无创呼吸机支持通气。观察组在对照组治疗的基础上应用疏血通注射液治疗14 d。观察两组患者的D-二聚体水平及血液流变学指标的变化。结果:治疗后观察组D-二聚体水平明显下降,血液流变学指标显著改善(P<0.05)。结论:疏血通注射液有助于改善慢性肺源性心脏病合并心房颤动的高凝状态,并可能降低心房颤动患者的血栓栓塞危险。
Objective：The Objective of this article is to analyze the clinical effect of Shuxuetong injection on patients with chronic pulmonary heart disease complicated with atrial fibrillation. Methods：68 patients were randomly divided into observation group and control group,each 34. Two groups of the patients were routinely given low-flow oxygen,phlegm and asthma,balance between water and electrolyte,and balance of PH level,etc. Complicated patients were offered sensitive antibiotic treatment by pathogens,and non-invasive ventilator support Ventilation if necessary.Apart from employing the measures of treatment to the control group,the observation group was treated with Shuxuetong injection for 14 days,before observing the change of D-dimer level and hemorheology index between two groups.Results：The level of D-dimer was significantly decreased after the treatment in the observation group（P〈0.05）.Conclusion：Shuxuetong injection can improve the hypercoagulable state of chronic pulmonary heart disease with atrial fibrillation and may reduce the risk of thromboembolism in patients with atrial fibrillation.
出处
《岭南急诊医学杂志》
2017年第3期242-244,共3页
Lingnan Journal of Emergency Medicine
关键词
疏血通注射液
慢性肺源性心脏病
心房颤动
shuxuetong injection
chronic pulmonary heart disease
atrial fibrillation
